It is ASHI’s 40th Anniversary and we want you to join us as we commemorate this great occasion at our annual meeting in Denver, Colorado. Come experience five days of educational programming designed to provide you with comprehensive state-of-the-art updates and glimpses into the future of the fields of genomics, immunogenetics, immunology, histocompatibility and transplantation.
After attending this meeting, participants will be able to identify important roles for histocompatibility and immune system genes that reach beyond transplantation, new ways to expand opportunities for transplantation and current best practices for selecting donors for both hematopoietic stem cell and organ transplantation. They will also be able to more critically assess various aspects of laboratory testing, from detection of clinically relevant antibodies to the very latest methods for HLA typing and for analyzing test results.
Join Us as We Celebrate the Past and Change the Future of Immunogenetics!
The 40th ASHI Annual Meeting will provide participants with comprehensive state-of-the-art updates and glimpses into the future on a variety of topics related to the fields of genomics, immunogenetics, immunology, histocompatibility and transplantation. The keynote address will set the stage with a discussion of medical applications of the new supercomputers like "Watson" - a lot has happened since that computer first learned to play Jeopardy and beat the best-of-the-best champions. Plenary and symposium sessions will then update participants on the ever-increasing knowledge about the role of HLA molecules as risk or protection factors for HIV, influenza, drug and pollen allergies, malaria and narcolepsy; on new ways of using typing for HLA and immune system genes for matching and for understanding human population history; and on exciting new approaches to getting more people transplanted. A joint AABB-ASHI symposium will also enlighten participants about how ABO types affect transplantation.
The exhibits complement the clinical and scientific content of the meeting by exposing attendees to the latest developments in products and services used by immunologists, geneticists, molecular biologists, transplant physicians, surgeons, pathologists and technologists involved in histocompatibility and immunogenetics.
Each year, the exhibits are an integral part of the American Society for Histocompatibility and Immunogenetics (ASHI) Annual Meeting. The ASHI Annual Meeting combines cutting-edge scientific and clinical sessions, workshops and vendor sponsored presentations along with innovative exhibits to provide an excellent educational experience for attendees. This year’s meeting will be no exception. Through the vendor exhibits, attendees are exposed to the latest products and services related to their field of research or area of clinical practice. We hope you will take this opportunity to ensure your products and services are showcased to this targeted audience by joining us in Denver, Colorado. Reserve your space today!
Why Exhibit with ASHI
More Face to Face Time
Attend ASHI and exhibitors can expect to have more face to face time with attendees. Here’s your chance to grab the attention of your target audience and build real relationships.
Reach Your Target Audience
At the Annual ASHI Meeting, your company will be able to reach a diverse group of individuals in the areas of transplant immunology, autoimmunity, vaccines and immunogenetics. Included among ASHI members are immunologists, geneticists, molecular biologists, transplant physicians and surgeons, pathologists and technologists involved in both basic research and clinical studies.
The American Society for Histocompatibility and Immunogenetics (ASHI) is a not-for-profit association of clinical and research professionals including immunologists, geneticists, molecular biologists, transplant physicians and surgeons, pathologists and technologists. As a professional society involved in histocompatibility, immunogenetics and transplantation, ASHI is dedicated to advancing the science and application of histocompatibility and immunogenetics; providing a forum for the exchange of information; and advocating the highest standards of laboratory testing in the interest of optimal patient care.